Remove Doctors Remove Life Science Remove Medicine Remove Reagent
article thumbnail

New Sandoz Board of Directors appointed

The Pharma Data

She is also a board member at BBI Solutions, a UK based diagnostic reagents and a Novo Holdings company. Karen will be Vice Chair of the future Board of Directors of Sandoz as well as the ad interim Chair of its Science, Innovation & Development Committee. Maria holds a Juris Doctor degree from the University of Palermo, Italy.

Sales 40
article thumbnail

Assay Development Scientist Jobs: What to Know About the Field

XTalks

This could involve tweaking experimental conditions, changing reagents or redesigning the assay. This specialization can often be achieved during graduate research, post-doctoral work or industry-specific training programs. Interning provides industry-relevant experience and can also help with networking. PCR, flow cytometry).

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Turning science into business: An optimised alternative to antibodies

Drug Discovery World

DS: What motivated you and Dr David Bunka, CTO, to create Aptamer and did you imagine you would one day be operating on such a global scale?    AT : We initially met at the University of Leeds, where David was a post-doctoral researcher studying aptamers, and I was completing my PhD.

article thumbnail

Transitioning Between Academia and Industry: Advice from Leading Scientists That Made the Switch

XTalks

In the beginning, I always thought I wanted to be a doctor, but then I felt it was very depressing, particularly at that time and in that particular field. So, I [decided] to go into research rather than be a doctor and see patients [such as that] young, beautiful life that you could do nothing about it.”.

article thumbnail

The evolution of assays for immuno-oncology research

Drug Discovery World

Reagents that can augment and enhance ADCC are of interest in addition to the antibodies themselves. Genetically engineered mouse models in oncology research and cancer medicine. As a result, the data generated will more accurately reflect the way that these cells interact in the body. EMBO Mol Med 2017;9:137–53.doi:10.15252/emmm.201606857pmid:[link]

article thumbnail

Flow cytometry technologies and cancer associated fibroblasts

Drug Discovery World

Dr Amber Miller, Flow Cytometry Scientist, Fortis Life Sciences, says flow cytometry techniques can help our understanding of cancer associated fibroblasts but there is still work to be done. She completed her PhD and post-doctoral training at Baylor College of Medicine. Elaldi et al. Comparing technologies. 2016.04.019.